# Applied Energetics, Inc.: financial statements, quarterly

AERG · OTC · CIK 879911 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aerg.md) · [Financials](/companies/aerg/financials.md) · [Filings](/companies/aerg/filings.md) · [Insiders](/companies/aerg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/aerg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [713](/filings/0001213900-24-097856.md) | [872 d](/filings/0001013762-25-003924.md) | [134](/filings/0001213900-25-043482.md) | [781](/filings/0001213900-25-075742.md) | [748](/filings/0001213900-25-109366.md) | [764 d](/filings/0001213900-26-036517.md) | [210](/filings/0001213900-26-056008.md) | [70.3](/filings/0001213900-26-089178.md) | [109](/filings/0001213900-25-109366.md) | [72.7 d](/filings/0001213900-26-036517.md) | not reported | [62.0](/filings/0001213900-26-089178.md) |
| Cost of revenue | $k | [174](/filings/0001213900-24-097856.md) | [145 d](/filings/0001013762-25-003924.md) | [274](/filings/0001213900-25-043482.md) | [384](/filings/0001213900-25-075742.md) | [509](/filings/0001213900-25-109366.md) | [313 d](/filings/0001213900-26-036517.md) | [63.9](/filings/0001213900-26-056008.md) | [47.5](/filings/0001213900-26-089178.md) | [53.4](/filings/0001213900-25-109366.md) | [47.8 d](/filings/0001213900-26-036517.md) | not reported | [21.6](/filings/0001213900-26-089178.md) |
| Gross profit | $k | [538](/filings/0001213900-24-097856.md) | [727 d](/filings/0001013762-25-003924.md) | [(140)](/filings/0001213900-25-043482.md) | [396](/filings/0001213900-25-075742.md) | [239](/filings/0001213900-25-109366.md) | [451 d](/filings/0001213900-26-036517.md) | [146](/filings/0001213900-26-056008.md) | [22.8](/filings/0001213900-26-089178.md) | [55.6](/filings/0001213900-25-109366.md) | [24.8 d](/filings/0001213900-26-036517.md) | not reported | [40.4](/filings/0001213900-26-089178.md) |
| Research and development | $k | [54.2](/filings/0001213900-24-097856.md) | [66.8 d](/filings/0001013762-25-003924.md) | [80.8](/filings/0001213900-25-043482.md) | [37.9](/filings/0001213900-25-075742.md) | [70.2](/filings/0001213900-25-109366.md) | [50.1 d](/filings/0001213900-26-036517.md) | [323](/filings/0001213900-26-056008.md) | [336](/filings/0001213900-26-089178.md) | [456](/filings/0001213900-25-109366.md) | [555 d](/filings/0001213900-26-036517.md) | [375](/filings/0001213900-26-056008.md) | [699](/filings/0001213900-26-089178.md) |
| Operating income | $k | [(1,830)](/filings/0001213900-24-097856.md) | [(1,797) d](/filings/0001013762-25-003924.md) | [(2,613)](/filings/0001213900-25-043482.md) | [(2,061)](/filings/0001213900-25-075742.md) | [(2,375)](/filings/0001213900-25-109366.md) | [(2,128) d](/filings/0001213900-26-036517.md) | [(3,106)](/filings/0001213900-26-056008.md) | [(3,786)](/filings/0001213900-26-089178.md) | [(3,971)](/filings/0001213900-25-109366.md) | [(4,068) d](/filings/0001213900-26-036517.md) | [(3,830)](/filings/0001213900-26-056008.md) | [(4,300)](/filings/0001213900-26-089178.md) |
| Interest expense | $k | [1.9](/filings/0001213900-23-086147.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(1,811)](/filings/0001213900-24-097856.md) | [(1,783) d](/filings/0001013762-25-003924.md) | [(2,611)](/filings/0001213900-25-109366.md) | [(2,061)](/filings/0001213900-25-109366.md) | [(2,375)](/filings/0001213900-25-109366.md) | [(2,128) d](/filings/0001213900-26-036517.md) | [(3,106)](/filings/0001213900-26-089178.md) | [(3,786)](/filings/0001213900-26-089178.md) | [(3,971)](/filings/0001213900-25-109366.md) | [(4,010) d](/filings/0001213900-26-036517.md) | [(3,808)](/filings/0001213900-26-089178.md) | [(4,279)](/filings/0001213900-26-089178.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001213900-24-097856.md) | not reported | [0.00](/filings/0001213900-25-043482.md) | [(0.01)](/filings/0001213900-25-075742.md) | [(0.01)](/filings/0001213900-25-109366.md) | not reported | [(0.01)](/filings/0001213900-26-056008.md) | [(0.02)](/filings/0001213900-26-089178.md) | [(0.02)](/filings/0001213900-25-109366.md) | not reported | [(0.02)](/filings/0001213900-26-056008.md) | [(0.02)](/filings/0001213900-26-089178.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0001213900-24-097856.md) | not reported | [0.00](/filings/0001213900-25-043482.md) | [(0.01)](/filings/0001213900-25-075742.md) | [(0.01)](/filings/0001213900-25-109366.md) | not reported | [(0.01)](/filings/0001213900-26-056008.md) | [(0.02)](/filings/0001213900-26-089178.md) | [(0.02)](/filings/0001213900-25-109366.md) | not reported | [(0.02)](/filings/0001213900-26-056008.md) | [(0.02)](/filings/0001213900-26-089178.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | not reported | [1,320](/filings/0001013762-25-003924.md) | [1,008](/filings/0001213900-24-042336.md) | [2,794](/filings/0001213900-24-067762.md) | [1,608](/filings/0001213900-24-097856.md) | [165](/filings/0001213900-25-043482.md) | [4,285](/filings/0001213900-25-043482.md) | [866](/filings/0001213900-25-075742.md) | [1,332](/filings/0001213900-25-109366.md) | [6,436](/filings/0001213900-26-089178.md) | [4,064](/filings/0001213900-26-056008.md) | [1,117](/filings/0001213900-26-089178.md) |
| Current assets | $k | [3,017](/filings/0001213900-23-086147.md) | [2,036](/filings/0001013762-25-003924.md) | [1,668](/filings/0001213900-24-042336.md) | [3,302](/filings/0001213900-24-067762.md) | [2,026](/filings/0001213900-24-097856.md) | [665](/filings/0001213900-26-036517.md) | [4,530](/filings/0001213900-25-043482.md) | [1,217](/filings/0001213900-25-075742.md) | [1,819](/filings/0001213900-25-109366.md) | [6,969](/filings/0001213900-26-089178.md) | [4,649](/filings/0001213900-26-056008.md) | [2,210](/filings/0001213900-26-089178.md) |
| Total assets | $k | [4,415](/filings/0001213900-23-086147.md) | [3,542](/filings/0001013762-25-003924.md) | [3,074](/filings/0001213900-24-042336.md) | [4,664](/filings/0001213900-24-067762.md) | [3,509](/filings/0001213900-24-097856.md) | [2,071](/filings/0001213900-26-036517.md) | [5,930](/filings/0001213900-25-043482.md) | [3,531](/filings/0001213900-25-075742.md) | [4,016](/filings/0001213900-25-109366.md) | [9,065](/filings/0001213900-26-089178.md) | [6,629](/filings/0001213900-26-056008.md) | [4,069](/filings/0001213900-26-089178.md) |
| Current liabilities | $k | [953](/filings/0001213900-23-086147.md) | [927](/filings/0001013762-25-003924.md) | [2,154](/filings/0001213900-24-042336.md) | [698](/filings/0001213900-24-067762.md) | [889](/filings/0001213900-24-097856.md) | [732](/filings/0001213900-26-036517.md) | [766](/filings/0001213900-25-043482.md) | [995](/filings/0001213900-25-075742.md) | [924](/filings/0001213900-25-109366.md) | [840](/filings/0001213900-26-089178.md) | [937](/filings/0001213900-26-056008.md) | [1,398](/filings/0001213900-26-089178.md) |
| Total liabilities | $k | [1,994](/filings/0001213900-23-086147.md) | [1,922](/filings/0001013762-25-003924.md) | [3,101](/filings/0001213900-24-042336.md) | [1,592](/filings/0001213900-24-067762.md) | [1,907](/filings/0001213900-24-097856.md) | [1,678](/filings/0001213900-26-036517.md) | [1,637](/filings/0001213900-25-043482.md) | [1,832](/filings/0001213900-25-075742.md) | [4,746](/filings/0001213900-25-109366.md) | [1,505](/filings/0001213900-26-089178.md) | [1,513](/filings/0001213900-26-056008.md) | [1,884](/filings/0001213900-26-089178.md) |
| Long-term debt | $k | [51.8](/filings/0001213900-23-086147.md) | not reported | [189](/filings/0001213900-24-042336.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $k | [2,421](/filings/0001213900-24-097856.md) | [1,620](/filings/0001213900-26-036517.md) | [(26.5)](/filings/0001213900-25-109366.md) | [3,072](/filings/0001213900-25-109366.md) | [1,602](/filings/0001213900-25-109366.md) | [393](/filings/0001213900-26-089178.md) | [4,292](/filings/0001213900-26-089178.md) | [1,700](/filings/0001213900-26-089178.md) | [(730)](/filings/0001213900-25-109366.md) | [7,560](/filings/0001213900-26-089178.md) | [5,116](/filings/0001213900-26-089178.md) | [2,185](/filings/0001213900-26-089178.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(509) d](/filings/0001213900-24-097856.md) | [(873) d](/filings/0001013762-25-003924.md) | [(1,542)](/filings/0001213900-25-043482.md) | [(1,128) d](/filings/0001213900-25-075742.md) | [(1,064) d](/filings/0001213900-25-109366.md) | [(1,359) d](/filings/0001213900-26-036517.md) | [(1,732)](/filings/0001213900-26-056008.md) | [(2,396) d](/filings/0001213900-26-089178.md) | [(2,490) d](/filings/0001213900-25-109366.md) | [(2,620) d](/filings/0001213900-26-036517.md) | [(2,296)](/filings/0001213900-26-056008.md) | [(2,828) d](/filings/0001213900-26-089178.md) |
| Capital expenditure | $k | [107 d](/filings/0001213900-24-097856.md) | [191 d](/filings/0001013762-25-003924.md) | not reported | not reported | [0.0 d](/filings/0001213900-25-109366.md) | [43.4 d](/filings/0001213900-26-036517.md) | [114](/filings/0001213900-26-056008.md) | [1,037 d](/filings/0001213900-26-089178.md) | [30.1 d](/filings/0001213900-25-109366.md) | [53.1 d](/filings/0001213900-26-036517.md) | [43.4](/filings/0001213900-26-056008.md) | [37.1 d](/filings/0001213900-26-089178.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2021 (2021-03-31) | Q1 FY2022 (2022-03-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [195](/filings/0001213900-22-027024.md) | [208](/filings/0001213900-22-027024.md) | [211](/filings/0001213900-24-042336.md) | [211](/filings/0001213900-24-067762.md) | [211](/filings/0001213900-24-097856.md) | [211](/filings/0001213900-24-042336.md) | [213](/filings/0001213900-24-067762.md) | [214](/filings/0001213900-24-097856.md) | [217](/filings/0001213900-26-056008.md) | [222](/filings/0001213900-26-089178.md) | [230](/filings/0001213900-26-056008.md) | [230](/filings/0001213900-26-089178.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 230,105,003 at 2026-08-12, from the cover of the [10-Q filed 2026-08-13](/filings/0001213900-26-089178.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.